Toll gates to periodontal host modulation and vaccine therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

1. Immune-Mediated Bidirectional Causality Between Inflammatory Bowel Disease and Chronic Periodontitis: Evidence from Mendelian Randomization and Integrative Bioinformatics Analysis.Biomedicines · 2025
   Article
2. Macrophages in periodontitis: A dynamic shift between tissue destruction and repair.The Japanese dental science review · 2022
   Review
3. Medicinal Plants Used as an Alternative to Treat Gingivitis and Periodontitis.Evidence-based complementary and alternative medicine : eCAM · 2022
   Review
4. Exploratory Algorithm of a Multi-epitope-based Subunit Vaccine Candidate AgainstInternational journal of peptide research and therapeutics · 2022
   Article
5. Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss.Acta biomaterialia · 2021
   Article
6. Contribution of Statins towards Periodontal Treatment: A Review.Mediators of inflammation · 2019
   Review
7. MyD88-mediated innate sensing by oral epithelial cells controls periodontal inflammation.Archives of oral biology · 2018
   Article
8. Host modulation therapy: An indispensable part of perioceutics.Journal of Indian Society of Periodontology · 2014
   Review
9. RANKL expression in periodontal disease: where does RANKL come from?BioMed research international · 2014
   Review
10. Complement-targeted therapeutics in periodontitis.Advances in experimental medicine and biology · 2013
    Review
11. Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen.PloS one · 2013
    Article
12. Inhibition of Porphyromonas gingivalis-induced periodontal bone loss by CXCR4 antagonist treatment.Molecular oral microbiology · 2012
    Article
13. Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist.Journal of immunology (Baltimore, Md. : 1950) · 2012
    Article
14. Baicalin downregulates Porphyromonas gingivalis lipopolysaccharide-upregulated IL-6 and IL-8 expression in human oral keratinocytes by negative regulation of TLR signaling.PloS one · 2012
    Article
15. Complement and periodontitis.Biochemical pharmacology · 2010
    Review
16. Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.Periodontology 2000 · 2010
    Review
17. Toll gates: An emerging therapeutic target.Journal of Indian Society of Periodontology
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as